1-15 of 386
The Future of Pediatric Atopic Dermatitis Treatment
On the Frontlines of Pediatric Skin HealthThe Future of Pediatric Atopic Dermatitis Treatment
Brian P. McDonough, MD, FAAFP
Mercedes Gonzalez, MD
When Is It Time to Move Beyond Topicals in Pediatric Atopic Dermatitis?
On the Frontlines of Pediatric Skin HealthWhen Is It Time to Move Beyond Topicals in Pediatric Atopic Dermatitis?
Brian P. McDonough, MD, FAAFP
Mercedes Gonzalez, MD
Managing Chronic Spontaneous Urticaria in Everyday Practice
On the Frontlines of Chronic Spontaneous UrticariaManaging Chronic Spontaneous Urticaria in Everyday Practice
Charles Turck, PharmD, BCPS, BCCCP
Jennifer Murase, MD
The Evolving Science of Chronic Spontaneous Urticaria
On the Frontlines of Chronic Spontaneous UrticariaThe Evolving Science of Chronic Spontaneous Urticaria
Gates B. Colbert, MD
Gordon Sussman, MD, FRCPC, FACP, FAAAAI
IL-31’s Role in Atopic Dermatitis and Prurigo Nodularis: Neuroimmune Insights
DermConsultIL-31’s Role in Atopic Dermatitis and Prurigo Nodularis: Neuroimmune Insights
Raj Chovatiya, MD, PhD, MSCI, FAAD
Nicholas Mollanazar, MD
Personalizing Systemic Therapy in Atopic Dermatitis and Prurigo Nodularis
DermConsultPersonalizing Systemic Therapy in Atopic Dermatitis and Prurigo Nodularis
Raj Chovatiya, MD, PhD, MSCI, FAAD
Peter A. Lio, MD
- advertisement
Making Skin Procedures Less Scary for Kids
On the Frontlines of Pediatric Skin HealthMaking Skin Procedures Less Scary for Kids
Cheryl Bayart, MD, MPH
Understanding the Emotional Impact of Pediatric Skin Disease
On the Frontlines of Pediatric Skin HealthUnderstanding the Emotional Impact of Pediatric Skin Disease
Cheryl Bayart, MD, MPH
Recognizing the Mental Burden of Psoriasis
On the Frontlines of PsoriasisRecognizing the Mental Burden of Psoriasis
Mio Nakamura, MD, MS
Steve Jackson, PharmD
How Advances in Immunology Are Shaping CSU Care
On the Frontlines of Chronic Spontaneous UrticariaHow Advances in Immunology Are Shaping CSU Care
Steve Jackson, PharmD
Christopher Bunick, MD, PhD, FAAD
Anti-IgE Therapies and the Future of CSU Care
On the Frontlines of Chronic Spontaneous UrticariaAnti-IgE Therapies and the Future of CSU Care
Gates B. Colbert, MD
Thomas Casale, MD
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Living RheumIL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
- advertisement
The Cardiovascular Dimension of Psoriatic Arthritis
Living RheumThe Cardiovascular Dimension of Psoriatic Arthritis
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Living RheumSpot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
Avery H. LaChance, MD, MPH, FAAD
